Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis

Stroke

Volumn 42, Issue 2, 2011, Pages 501-503

  Cesarman Maus, Gabriela ^a   Cantú Brito, Carlos ^b   Barinagarrementeria, Fernando ^c   Villa, Rosario ^b   Reyes, Elba ^d   Sanchez Guerrero, Jorge ^b   Hajjar, Katherine A ^e   Latorre, Ethel Garcia ^d  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c Hospital Angeles Queretaro   (Mexico)

^d INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

annexin A2; antiphospholipid syndrome; cerebral venous thrombosis; thrombophilia

Indexed keywords

AUTOANTIBODY; FIBRINOLYTIC FACTOR; LIPOCORTIN 2;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CEREBRAL SINUS THROMBOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; VEIN THROMBOSIS;

ADOLESCENT; ADULT; ANNEXIN A2; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; FIBRINOLYSIS; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 79251640440     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.592121     Document Type: Article

References (12)

1. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementería F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on serebral vein and dural sinus thrombosis (ISCVT). Stroke. 2004;35:664-670.
2. Cantú C, Alonso E, Jara A, Martínez L, Ríos C, Fernandez ML, García I, Barinagarrementería F. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke. 2004;35:1790-1794.
3. Cervera R, Boffa M, Khamashta MA, Hughes GR. The Europhospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009;18:889-893.
4. Cesarman-Maus G, Rios-Luna N, Deora AB, Villa R, Cravioto M, Alarcon-Segovia D, Sanchez-Guerrero, Hajjar KA. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood. 2006;107:4375-4382.
5. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, Van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994; 369:14-15.
6. Ma K, Simantov R, Zhang JC, Silverstein RL, Hajjar KA, McCrae KR. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem. 2000;275:15541-15548.
7. Meroni PL, Sepp N, Tincani A, Raschi E, Testoni C, Corsini E, Cavazzana I, Pellegrini S, Salmaggi A. Endothelium and the brain in CNS lupus. Lupus. 2003;12:919-928.
8. Kwaan HC, Wang J, Weiss I. Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin. J Thromb Haemost. 2004;2:306-312.
9. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet. 2005;37:435-440.
10. Ao W, Zheng H, Chen XW, Shen Y, Yang CD. Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis. Rheumatol Int 2010;[Epub ahead of print] PMID: 20229030.
11. Salle V, Mazière JC, Smail A, Cévallos R, Mazière C, Fuentes V, Tramier B, Makdassi R, Choukroun G, Vittecoq O, Goëb V, Ducroix JP. Antiannexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome. J Clin Immunol. 2008;28:291-297.
12. Meroni PL, Raschi E, Testoni C. Endothelium as a target for antiphospholipid antibodies and for therapeutical intervention. Autoimmun Rev. 2002;1:55-60.